A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, Version 1.0. Lyon: IARCPress; 2001. American Cancer Society caner facts and figures 2004. 2004. Internet Communication. Rougier, 2003, Epidemiology, treatment and chemoprevention in colorectal cancer, Ann Oncol, 14, ii3, 10.1093/annonc/mdg722 Ilyas, 1999, Genetic pathways in colorectal and other cancers, Eur J Cancer, 35, 335, 10.1016/S0959-8049(98)00431-6 Cottrell, 1992, Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas, Lancet, 340, 626, 10.1016/0140-6736(92)92169-G Bendardaf, 2004, Prognostic and predictive molecular markers in colorectal carcinoma, Anticancer Res, 24, 2519 Vogelstein, 1988, Genetic alterations during colorectal-tumor development, N Engl J Med, 319, 525, 10.1056/NEJM198809013190901 Fearon, 1990, Identification of a chromosome 18q gene that is altered in colorectal cancers, Science, 247, 49, 10.1126/science.2294591 Zetter, 1993, Adhesion molecules in tumor metastasis, Semin Cancer Biol, 4, 219 Jen, 1994, Allelic loss of chromosome 18q and prognosis in colorectal cancer, N Engl J Med, 331, 213, 10.1056/NEJM199407283310401 Alderson, 2004 Moher, 1999, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses, Lancet, 354, 1896, 10.1016/S0140-6736(99)04149-5 Parmar, 1998, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 Choi, 2002, Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival, Clin Cancer Res, 8, 2311 Rooney, 2001, Colorectal cancer genomics: evidence for multiple genotypes which influence survival, Br J Cancer, 85, 1492, 10.1054/bjoc.2001.2095 Lindforss, 2000, Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma, Cancer, 88, 2661, 10.1002/1097-0142(20000615)88:12<2661::AID-CNCR3>3.0.CO;2-Q Cohn, 1997, The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study, Cancer, 79, 233, 10.1002/(SICI)1097-0142(19970115)79:2<233::AID-CNCR6>3.3.CO;2-U Gerdes, 1995, Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors, Anticancer Res, 15, 13 Laurent-Puig, 1992, Survival and acquired genetic alterations in colorectal cancer, Gastroenterology, 102, 1136, 10.1016/0016-5085(92)70006-W Knosel, 2003, Genetic imbalances with impact on survival in colorectal cancer patients, Histopathology, 43, 323, 10.1046/j.1365-2559.2003.01720.x Bardi, 2004, Tumor karyotype predicts clinical outcome in colorectal cancer patients, J Clin Oncol, 22, 2623, 10.1200/JCO.2004.11.014 Martinez-Lopez, 1998, Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer, Gastroenterology, 114, 1180, 10.1016/S0016-5085(98)70423-8 Font, 2001, Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer, Dis Colon Rectum, 44, 549, 10.1007/BF02234328 Watanabe, 2001, Molecular predictors of survival after adjuvant chemotherapy for colon cancer, N Engl J Med, 344, 1196, 10.1056/NEJM200104193441603 Barratt, 2002, DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study, Lancet, 360, 1381, 10.1016/S0140-6736(02)11402-4 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Cochran, 1954, The combination of estimates from different experiments, Biometrics, 10, 101, 10.2307/3001666 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446 Duval, 2000, Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x Aschele, 2004, Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy, J Clin Oncol, 22, 3758, 10.1200/JCO.2004.08.066 Bardi, 1993, Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features, Cancer, 71, 306, 10.1002/1097-0142(19930115)71:2<306::AID-CNCR2820710207>3.0.CO;2-C Carethers, 1998, Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer, Gastroenterology, 114, 1188, 10.1016/S0016-5085(98)70424-X Curran, 2000, Replication error phenotype, clinicopathological variables, and patient outcome in Dukes’ B stage II (T3,N0,M0) colorectal cancer, Gut, 46, 200, 10.1136/gut.46.2.200 De Angelis, 2001, Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer, Int J Colorectal Dis, 16, 38, 10.1007/s003840000275 Diep, 2003, Genetic tumor markers with prognostic impact in Dukes’ stages B and C colorectal cancer patients, J Clin Oncol, 21, 820, 10.1200/JCO.2003.05.190 Dix, 1994, The common molecular genetic alterations in Dukes’ B and C colorectal carcinomas are not short-term prognostic indicators of survival, Int J Cancer, 59, 747, 10.1002/ijc.2910590606 Halling, 1999, Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers, J Natl Cancer Inst, 91, 1295, 10.1093/jnci/91.15.1295 Jernvall, 1999, Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers, Eur J Cancer, 35, 197, 10.1016/S0959-8049(98)00306-2 Kern, 1989, Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected], JAMA, 261, 3099, 10.1001/jama.261.21.3099 Kochhar, 1997, Allelic imbalance and microsatellite instability in resected Duke’s D colorectal cancer, Diagn Mol Pathol, 6, 78, 10.1097/00019606-199704000-00002 Lanza, 1998, Chromosome 18q allelic loss and prognosis in stage II and III colon cancer, Int J Cancer, 79, 390, 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.0.CO;2-9 Massa, 1999, Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer, Eur J Cancer, 35, 1676, 10.1016/S0959-8049(99)00158-6 O’Connell, 1992, Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?, Cancer, 70, 1732, 10.1002/1097-0142(19920915)70:4+<1732::AID-CNCR2820701614>3.0.CO;2-# Offerhaus, 1992, The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma, Gastroenterology, 102, 1612, 10.1016/0016-5085(92)91721-F Ogunbiyi, 1998, Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator, J Clin Oncol, 16, 427, 10.1200/JCO.1998.16.2.427 Ookawa, 1993, Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma, Int J Cancer, 53, 382, 10.1002/ijc.2910530307 Peng, 2003, Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer, Int J Gastrointest Cancer, 34, 39, 10.1385/IJGC:34:1:39 Saito, 1999, Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis, Oncology, 56, 134, 10.1159/000011954 Shibata, 1996, The DCC protein and prognosis in colorectal cancer, N Engl J Med, 335, 1727, 10.1056/NEJM199612053352303 Slebos, 1996, Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma, Br J Cancer, 74, 165, 10.1038/bjc.1996.333 Vogelstein, 1989, Allelotype of colorectal carcinomas, Science, 244, 207, 10.1126/science.2565047 Young, 1994, Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers, Oncogene, 9, 1053 Zhou, 2002, Counting alleles to predict recurrence of early-stage colorectal cancers, Lancet, 359, 219, 10.1016/S0140-6736(02)07448-2 Zauber, 2004, Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients’ survival, J Clin Pathol, 57, 938, 10.1136/jcp.2004.017814 Benson, 2004, American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer, J Clin Oncol, 22, 3408, 10.1200/JCO.2004.05.063 Tomlinson, 2002, Loss of heterozygosity analysis: practically and conceptually flawed?, Gen Chromosom Cancer, 34, 349, 10.1002/gcc.10085 Dickersin, 1992, Meta-analysis: state-of-the-science, Epidemiol Rev, 14, 154, 10.1093/oxfordjournals.epirev.a036084 Sacks, 1987, Meta-analyses of randomized controlled trials, N Engl J Med, 316, 450, 10.1056/NEJM198702193160806 Mazelin, 2004, Netrin-1 controls colorectal tumorigenesis by regulating apoptosis, Nature, 431, 80, 10.1038/nature02788